|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01795794 |
|
Date of registration:
|
11/02/2013 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Evaluation of the Efficacy in Decreasing Iron Absorption in Patients With Congenital Dyserythropoietic Anemia Type I by Treatment With LOSEC
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
April 2013 |
|
Target sample size:
|
12 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01795794 |
|
Study type:
|
Interventional |
|
Study design:
|
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 4
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients with CDAI
- over 30 kg
- can swallow tablets
- ferritin levels higher than the normal range but still don't require treatment.
Exclusion Criteria:
- N.A
Age minimum:
12 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
CDA Type I
|
|
Intervention(s)
|
|
Drug: omeprazole
|
|
Primary Outcome(s)
|
|
evaluate number of adverse effects per patient treated with LOSEC + levels of iron, ferritin,complete blood count and chemistry panel.
[Time Frame: 1 year]
|
|
Secondary ID(s)
|
|
sor034612ctil
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|